Antitumor activity of Bortezomib alone and in combination with TRAIL in human acute myeloid leukemia.

被引：0
|
作者：
Conticello, Concetta [1 ]
Adamo, Luana [2 ]
Vicari, Luisa [2 ]
Giuffrida, Raffaella [2 ]
Iannolo, Gioacchin [2 ]
Anastasi, Gabriele [2 ]
Palumbo, Giuseppe A. [4 ]
Gulisano, Massimo [2 ]
De Maria, Ruggero [3 ]
Giustolisi, Rosario [4 ]
Di Raimondo, Francesco [4 ]
机构：
[1] Mediterranean Inst Oncol, Dept Expt Oncol, Viagrande, CT USA
[2] IOM Ric, Viagrande, CT USA
[3] Inst Superiore Sanita, Dept Hematol Oncol & Mol Med, Rome, Italy
[4] Univ Catania, Dept Biomed Sci, Hematol Sect, Catania, Italy
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4307.4307
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4307
引用
收藏
页码：144B / 144B
页数：1
相关论文
共 50 条
  • [21] Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia
    Gil, Lidia
    Styczynski, Jan
    Dytfeld, Dominik
    Debski, Robert
    Kazmierczak, Maciej
    Kolodziej, Beata
    Rafinska, Beata
    Kubicka, Malgorzata
    Nowicki, Adam
    Komarnicki, Mieczyslaw
    Wysocki, Mariusz
    ANTICANCER RESEARCH, 2007, 27 (6B) : 4021 - 4025
  • [22] Timing of response to venetoclax combination treatment in older patients with acute myeloid leukemia.
    Jonas, Brian Andrew
    Dinardo, Courtney Denton
    Pratz, Keith
    Wei, Andrew
    Hong, Wan-Jen
    Chyla, Brenda
    Duan, Yinghui
    Potluri, Jalaja
    Werner, Michael
    Pollyea, Daniel Aaron
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Efficacy of AMG 176 in combination with gilteritinib in preclinical models of acute myeloid leukemia.
    Chen, Xiaoyue
    Caenepeel, Sean
    Belmontes, Brian
    McElroy, Patricia L.
    Rex, Karen
    Osgood, Tao
    Hughes, Paul
    CANCER RESEARCH, 2021, 81 (13)
  • [24] Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia
    Spampinato, Mariarita
    Zuppelli, Tatiana
    Dulcamare, Ilaria
    Longhitano, Lucia
    Sambataro, Domenico
    Santisi, Annalisa
    Alanazi, Amer M.
    Barbagallo, Ignazio A.
    Vicario, Nunzio
    Parenti, Rosalba
    Romano, Alessandra
    Musumeci, Giuseppe
    Li Volti, Giovanni
    Palumbo, Giuseppe A.
    Di Raimondo, Francesco
    Nicolosi, Anna
    Giallongo, Sebastiano
    Del Fabro, Vittorio
    PHARMACEUTICALS, 2024, 17 (07)
  • [25] Peroxidase activity and nuclear density analysis in the diagnosis of acute myeloid leukemia.
    Gibbs, G
    BLOOD, 2005, 106 (11) : 212B - 212B
  • [26] Safety and activity of venetoclax in combination with high-dose cytarabine in children with relapsed or refractory acute myeloid leukemia.
    Karol, Seth E.
    Alexander, Thomas
    Das Gupta, Soumyasri
    Pounds, Stanley B.
    Canavera, Kristin
    Klco, Jeffery M.
    Lacayo, Norman James
    Pui, Ching-Hon
    Opferman, Joseph T.
    Rubnitz, Jeffrey E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Activity of carfilzomib (CFZ) alone and in combination with cytarabine and chloroquine diphosphate (CHQ) in acute myeloid leukemia (AML)
    Peng, Mao Yu
    Abaza, Yasmin
    Conklin, Dylan
    Von Euw, Erika
    Mead, Monica
    Timmerman, John
    Slamon, Dennis
    Larson, Sarah
    CANCER RESEARCH, 2019, 79 (13)
  • [28] Development of a novel xenotransplantation system for studying human acute myeloid leukemia.
    Park, Christopher Y.
    Majeti, Ravindra
    Tan, Brenton T.
    Weissman, Irving L.
    BLOOD, 2006, 108 (11) : 550A - 551A
  • [29] Secondary acute myeloid leukemia after treatment of acute monoblastic leukemia.
    Kebelmann-Betzing, C
    Seeger, K
    Kulozik, A
    Henze, G
    Liehr, T
    Heller, A
    Teigler-Schlegel, A
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (25): : 1897 - 1898
  • [30] A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia
    Tomlinson, Benjamin K.
    Tuscano, Joseph M.
    Abedi, Mehrdad
    Welborn, Jeanna
    Arora, Mili
    O'Donnell, Robert T.
    Wun, Ted
    Jonas, Brian A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (11) : E291 - E294
12345